Skip to content

MAGIL

Active Private limited companyfounded 2017active for 9 yearsBoulevard d'Avroy 7C, 4000 LiègeKBO/BCE: BE 0671.892.472

Lifetime

9 annual accounts with figures on one time axis
peak €107,243 (2023)
€80,674▲ 4.5%
lowest -€5,867 (2017)
€55,369▲ 28.1%
peak €287,779 (2025)
€287,779▲ 23.8%
€6,689▼ 72.7%
peak 0.4 FTE (2018)
-not published
Board1 name since 2021
1 directorGILLOT Anne
Documentsfilings and deeds
13-07-202618 days before the deadline
2025micro format
Result from €43,230 to €55,369Equity from €232,410 to €287,779Debts from €24,488 to €6,689

Key points

from the 2025 annual accounts

Equity

€287,779 ▲ 23.8%

MAGIL has made a profit without a break since 2018.

Turnover

≈ €180,000 estimated

The micro format states no turnover.

Investments

€2,226 1.8 × depreciation
202120222025

Green is investment, beige is depreciation. Machinery stands 45.0% higher than in 2024.

Liquidity

43.56 was 10.40 in 2024

Short-term debts fell from €24,488 to €6,689.

Filings

9 annual accounts 2 late
AprilJune31 JulyOctober20202025

The 2024 accounts came latest: 53 days after the end of the period.

Position in the sector

97.7%

Higher solvency than 95% of companies in human health. Sector median 63.0% · 20,767 companies.

Checked score

95
Excellent
Financially stronger than 60% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

100=equity 97.7% of total assets
64-5short-term debt 2.3% · cash 11.0%
92+2return on assets 18.8%

Score breakdown

raises risk
1 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Equity €287,779 (97.7% of total assets)
Figures for financial year 2025 (filed on 13-07-2026)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 43% on liquidity, 49% on profitability and 68% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as MAGIL has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.4%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of MAGIL itself is lower: < 0.1% within 12 months. It rests on far more data about MAGIL than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for MAGIL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €25,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 43.56 (10.4 in 2024), above the usual 1.5. Short-term debt is 2.3% and cash 11% of total assets. 2.3% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 of the last 3 accounts late
NBB · filings
lowers risk · Equity €287,779 (97.7% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 13-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
18 days early
2024
53 days late
2023
29 days late
2022
5 days early
2021
2 days early
2020
39 days early
2019
11 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 1 day after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 July (4 of the last 5 accounts filed within 32 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

GA
Director
Board & ownership

Recent changes

Change of role: GILLOT Anne, from manager to director Director discharge: GILLOT Anne (manager) · General meeting of 15-11-2022 · Gazette deed
Incorporation published on 02-03-2017 · Gazette deed
First establishment -, Boulevard d'Avroy 7, Liège
All 20 events

Comparable companies

same main activity, similar in size and age
Company
MAGIL Liège €294,468 €80,674 97.7% -
NONUKA Asse €286,815 €76,426 92.9% -
Laurens De Greef Londerzeel €341,706 €76,678 52.1% -
DENTISTE ALLARD AUDREY Soumagne €250,730 €97,909 25.5% -
A.M. SMILE Comblain-au-Pont €304,518 €79,619 96.9% -
Cabinet Dentaire Pauline Collette Trooz €214,652 €91,449 9.5% -
BLYDE tda Oudsbergen €275,324 €84,104 83.9% -

These companies have the same main activity as MAGIL: dental practice (NACE 86230). They are comparable in size and age: total assets between €215,000 and €342,000, founded between 2013 and 2018.

Official details

Source: KBO
Status
Active since 28-02-2017Normal situation
Registered office
11 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 10 November 2026.
Activity
Dental practiceNACE 86230
Joint committee
330Health institutions and services · annual accounts 2025
Establishment unit
2.261.848.0774000 Liège, since 28-02-2017
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€294,468▲ 14.6%
Filing
Filed on 13-07-2026, 18 days before the end of the filing period
Financials

Insights on MAGIL

MAGIL files the micro format. That format states no turnover. The gross margin fell from €84,735 in 2017 to €80,674 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MAGIL

What is the company number of MAGIL?
The company number of MAGIL is 0671.892.472. The VAT number is the same number with BE in front: BE 0671.892.472.
Where is MAGIL based?
The registered office is at Boulevard d'Avroy 7C, 4000 Liège.Company details
What does MAGIL do?
According to the KBO register, the main activity is dental practice (NACE 86230).
What is the legal form of MAGIL?
MAGIL is a private limited company (BV).
When was MAGIL founded?
MAGIL was founded on 28-02-2017.
Is MAGIL still active?
Yes, MAGIL is an active enterprise in the KBO register.
How many employees does MAGIL have?
MAGIL had an average of 0.5 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
Which joint committee does MAGIL fall under?
In its 2025 annual accounts, MAGIL states joint committee 330 (Health institutions and services).
What is the turnover of MAGIL?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €80,674 and 32 comparable companies (NACE 862). It probably lies between €140,000 and €230,000.
Is MAGIL profitable?
In financial year 2025, MAGIL made a profit of €55,369.
Where can I find the annual accounts of MAGIL?
MAGIL filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MAGIL due?
MAGIL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.